Thrombolysis in Factor Xa-inhibitors Trial
A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 300 participants.
Also called NCT06878066
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 300 participants
- Sponsor
- Guri Hagberg
- Registry
-
NCT06878066 -
2023-509907-34-01
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Denmark, Norway, Sweden
- Registry status
- Recruiting
Technical summary
Registry record NCT06878066. Randomized; single masking; primary purpose treatment. Start 2025-03-14 (actual); primary completion 2028-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Thrombolysis in Factor Xa-inhibitors Trial
- Acronym
- SIFT
- Condition
- Stroke
- Condition
- Stroke (in Patients With Atrial Fibrillation)
- Condition
- Ischemic Stroke
- Condition
- Acute Ischemic Stroke
- Condition
- Anticoagulant Therapy
- Condition
- Factor Xa Inhibitor
- Condition
- Intracranial Hemorrhages
- Condition
- Hemorrhagic Transformation Due to Acute Stroke
- Condition
- Bleeding in the Brain
- Intervention (Drug)
- thrombolysis therapy
- Lead sponsor
- Guri Hagberg
- Collaborator
- Klinbeforsk
- Collaborator
- Clinical Trial Unit (CTU), Oslo University Hospital
Record details
- Record id
cardio:ct-nct06878066- Content hash
3247b8f6d46320992fbf5a348e462f23ede081ad00fd7f3caf1656ef49dbd89f